Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-070452
Filing Date
2025-05-13
Accepted
2025-05-13 16:36:39
Documents
70
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q vrca-20250331.htm   iXBRL 10-Q 1739174
2 EX-10.2 vrca-ex10_2.htm EX-10.2 79790
3 EX-31.1 vrca-ex31_1.htm EX-31.1 15121
4 EX-31.2 vrca-ex31_2.htm EX-31.2 15366
5 EX-32.1 vrca-ex32_1.htm EX-32.1 13512
  Complete submission text file 0000950170-25-070452.txt   8857448

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT vrca-20250331.xsd EX-101.SCH 1329280
73 EXTRACTED XBRL INSTANCE DOCUMENT vrca-20250331_htm.xml XML 1614930
Mailing Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380
Business Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380 484-453-3300
Verrica Pharmaceuticals Inc. (Filer) CIK: 0001660334 (see all company filings)

EIN.: 463137900 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38529 | Film No.: 25940799
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)